Epineuron Technologies Patents

Patent portfolio assigned to Epineuron Technologies (verified via public assignee records). Estimated patent count: 1. Canadian clinical-stage bioelectronic medicine company; PeriPulse nerve-regeneration device (FDA Breakthrough). Patent CN111511435A 'systems and methods for delivering nerve regeneration therapy' lists Epineuron Technologies Inc as assignee per Google Patents search. No named customers on own site (only journal publication venues). patent_count_estimate approximate.